| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Revenue | $38.6M | +29.8% |
| R&D Expense | $184.5M | +58.5% |
| SG&A Expense | $38.0M | +21.8% |
| Operating Income | -$183.9M | -56.0% |
| Pre-tax Income | -$180.4M | -54.1% |
| Income Tax | $0 | -100.0% |
| Net Income | -$180.4M | -53.9% |
| EPS (Basic) | -$3.71 | -35.9% |
| EPS (Diluted) | -$3.71 |
| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.5M | -19.9% |
| Short-term Investments | $244.7M | +13.7% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $318.4M | +2.4% |
| Total Assets | $416.8M | -12.6% |
| Current Liabilities | $70.7M | +6.6% |
| Total Liabilities | $113.1M | -15.9% |
| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$159.8M | -89.4% |
| Capital Expenditures | $12.2M | +116.3% |
| Investing Cash Flow | $27.2M | +125.1% |
| Financing Cash Flow | $117.2M | -23.8% |
| Free Cash Flow | -$172.1M | -91.1% |
| -35.9% |
| Stockholders' Equity |
| $303.7M |
| -11.3% |